Table 3 RE-AIM framework implementation outcomes used to evaluate the ICOPE program implementation
Framework dimension | Outcome |
|---|---|
Reach | • # and % of eligible patients who complete the pre-visit questionnaire • # and % of eligible PCPs who use the I-COPE order set • # and % of PCPs participating in ECHO-Chicago |
Effectiveness | • Change in a variety of recommended pain treatments • Change in prescribing of higher-risk pain treatments (opioids and Beer’s criteria medications) • Change in pain scores o % with chronic pain diagnoses and high initial pain scores (≥ 6) who experience a 30% reduction in scores in 6 months • Change in safe opioid prescribing practices o Annual drug screens in a patient with chronic opioid use o Naloxone prescribing in patients with > 50 MME equivalents of opioids or OUD o Co-prescribing of opioids and benzodiazepines • Change in self-efficacy and practice behaviors for ECHO-Chicago participants |
Adoption | • # and % of clinics who use the I-COPE Program |
Implementation | • # and % of eligible patients who received all I-COPE tools (pre-visit questionnaire and order set use) • # and % of PCPs who participated in ECHO-Chicago and attended all eight sessions |
Maintenance | • Outcomes listed above at 12 months |